Skip to content

Ultrasound Guided Sacral Erector Spinae Plane Block in Pediatric Anorectal Surgery

Analgesic Efficacy of Ultrasound Guided Sacral Erector Spinae Plane Block Versus Caudal Block in Pediatric Anorectal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04921007
Enrollment
60
Registered
2021-06-10
Start date
2021-08-13
Completion date
2022-07-01
Last updated
2022-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Keywords

Erector spinae plane block, Ultrasound guided, Sacral, Anorectal surgery

Brief summary

This study will be conducted to evaluate efficacy of ultrasound guided sacral erector spinae plane block for postoperative analgesia in pediatric anorectal surgery in comparison to caudal block.

Detailed description

Regional anesthesia in children has become increasingly popular over the past few decades. A variety of peripheral and central nerve blocks have been developed to ensure that perioperative pain can be effectively controlled. So, it possible to reduce the dose concentrations of systemic drugs and improved hemodynamic stability in high-risk patients. Erector spinae plane (ESP) block with various approaches been used in many surgeries and obtained great popularity despite of its novelty. After first description; lower thoracic, lumbar and sacral approaches were defined for postoperative analgesia. There are a few cases in which sacral ESP block was administered and reported. The aim of this study is to compare postoperative analgesic effect of ultrasound guided sacral ESP block and caudal block. It is hypothesized that sacral ESP block will be comparable to caudal block as a promising effective alternative for analgesia in patients who will undergo pediatric anorectal surgery with fewer side effects. This prospective, randomized, comparative clinical study will include 60 children who will be scheduled for elective anorectal surgery under general anesthesia in Mansoura university hospitals. Informed written consent will be obtained from parents of all subjects in the study after ensuring confidentiality. The study protocol will be explained to parents of all patients in the study who will be kept fasting prior to surgery. Patients will be randomly assigned to two equal groups (ESP and caudal) according to computer-generated table of random numbers using the permuted block randomization method. The collected data will be coded, processed, and analyzed using SPSS program. All data will be considered statistically significant if P value is ≤ 0.05.

Interventions

A high-frequency ultrasound linear probe covered with a sterile sheath will be placed longitudinally to the midline of the sacrum. The median sacral crests and erector spinae muscle will be visualized, then a 22-gauge, 50 mm needle will be advanced from cranial to caudal direction until its tip touch the sacral crest.

PROCEDURECaudal block

A high-frequency ultrasound linear probe covered with a sterile sheath will be placed on to the sacrococcygeal region. The dura mater, epidural space, conus medullaris, sacral cornua, and sacrococcygeal ligament will be identified. Using the in-plane technique, a 22-gauge, 50 mm needle will be introduced to reach the sacral epidural space.

DRUGBupivacaine Hydrochloride

Following negative aspiration, a precalculated dose (0.5 ml/kg) of 0.25% bupivacaine will be injected.

Sponsors

Sameh Fathy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiology (ASA) I and II patients. * Scheduled for pediatric anorectal surgery

Exclusion criteria

* Parental refusal of consent. * Children with developmental delays, mental or neurological disorders. * Bleeding or coagulation diathesis. * History of known sensitivity to the used anesthetics. * Infection or redness at the injection site.

Design outcomes

Primary

MeasureTime frameDescription
Duration for the first analgesic requestUp to 24 hours after the procedureThe time of the first analgesic request for paracetamol in minutes will be recorded.

Secondary

MeasureTime frameDescription
Improvement in pain scoresUp to 24 hours after the procedurePain score from 0 to 10 (0 = no pain and 10 = the worst imaginable pain) is assessed postoperatively at 1, 2, 4, 8, 12, 24 hours
Changes in heart rateUp to end of the surgeryHeart rate (beat/min) is recorded at ten-minute intervals until the end of the surgery.
Total analgesic requirements of paracetamolUp to 24 hours after the procedureThe amount of paracetamol consumption in milligrams given as a rescue analgesia
Changes in postoperative emergence agitation scaleUp to 30 minutes after the procedureAgitation is assessed using the 5- step Cravero scale (1-5) every five minutes from awakening and for 30 minutes.(1:Obtunded with no response to stimulation, 2:Asleep but responsive to movement or stimulation, 3:Awake and responsive, 4:Crying, 5:Thrashing behaviour that requires restraint)
Value of parent satisfaction from the procedureUp to 24 hours after the procedureThe parents will be investigated postoperatively for the quality of the procedure verbally (0-10; 0=None, 10=total satisfaction)
Changes in mean arterial blood pressureUp to end of the surgeryBlood pressure (mmHg) is recorded at ten-minute intervals until the end of the surgery.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026